Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone

NCT04325802 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Covid-19 pandemic

Conditions

Atopic Dermatitis
Pruritus
Pruritus Chronic
Dermatitis

Interventions

DRUG: Naltrexone
OTHER: Placebo

Sponsor

University of Minnesota